News and Announcements
Shivom Extends its Presale Until Friday April 27th, 2018!
- Published April 25, 2018 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Key Takeaways:
- Shivom extends presale to April 27th, 2018, 6 PM GMT
- Shivom receiving overwhelming response for currently presale
- Main crowdsale commences on May 3rd, 2018
Shivom in its bid to help registered users to complete their KYC has extended their Presale for another 2 days! This means you can still sign up for the OmiX Token presale until Friday, April 27th, 2018, 6 PM GMT. The bonus will remain consistently at 3% through the remaining days.
The decision to extend the Presale was taken due to the overwhelming response we have received thus far. Due to the backlog of KYC applications, we are allowing users a few more days to participate, before the main crowdsale commences on May 3rd, 2018. Please note that the crowdsale will not carry any bonuses.
If your KYC application is still incomplete, we recommend you complete it before the main public sale begins.
This also means that the Token Presale is still open for those who haven’t registered yet if you still wish to do so and benefit from the early bird bonuses. Become part of the Shivom’s future-changing project by simply signing up at https://shivom.io/.
Thank you for supporting Shivom in the future of genomic information storage and DNA sequencing. Your participation is vital to our vision and will help empower the next era of global healthcare.
Remember the Presale will end on April 27th, 2018 | 6 PM GMT
About Shivom
Shivom combines blockchain, A.I., DNA sequencing & cryptography to enable secure and personalized medicine. The Shivom platform works on collaboration & integrity, allowing people to own, manage and monetize their data. By creating a web-marketplace, a network of genomic counsellors, and a not-for-profit drug research unit, Shivom will build a global healthcare ecosystem, reaching even low-income countries.
Company Updates
The Index Approach in Early-Stage Venture Capital: Reconsidered
The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]
The Future Is Now: The Evolution of Dealflow with Wholesale Investor
If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]
Investability of a Startup: A Comprehensive Guide for Angels and High-Net Worth Investors
Venturing into the Startup Scene Let’s dive into the intriguing world of startups. It’s a thrilling ride, isn’t it? Like finding a pearl in an ocean, spotting a promising startup amidst a sea of businesses is no easy task. This guide aims to light the way, focusing on the “The Investability of a Startup: 7 […]
Backed By Leading Investment Groups and Family Offices
